Trials & Tribulations From clinician scientist to nonprofit CEO January 24, 2025Vol.51 No.03By E. Anders Kolb
Trials & Tribulations Chadi Nabhan: Why I wrote a book about cancer January 17, 2025Vol.51 No.02By Chadi Nabhan
FreeTrials & Tribulations New colorectal cancer screening strategies must advance the standard of care January 10, 2025Vol.51 No.01By Paul J. Limburg
Trials & Tribulations Menin inhibitors emerge as new treatment for advanced AML November 22, 2024Vol.50 No.44By Ghayas Issa
Trials & Tribulations How we improved the treatment of Hodgkin lymphoma November 15, 2024Vol.50 No.43By Alex Herrera
Trials & Tribulations A study measures the long-term downside of prostate cancer screeningA paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment November 08, 2024Vol.50 No.42By Otis W. Brawley
Trials & Tribulations Addressing high cancer mortality in Native Hawaiian and Pacific Islander populationsA call for equity in cancer research November 01, 2024Vol.50 No.41By Naoto T. Ueno
Trials & Tribulations Cancer clinical trials shouldn’t discriminate—but they do October 11, 2024Vol.50 No.38By Erin Miller
Trials & Tribulations A simple intervention could help address overlooked pain among older adults with cancer in rural America September 13, 2024Vol.50 No.34By Megan J. Shen
Trials & Tribulations Is gastrectomy indicated?A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations? September 06, 2024Vol.50 No.33By Rebecca Sutphen, Sue Friedman and Jon Florin
